Pricing Log in Create free account

Nutriband Inc. (NTRB) vs OKYO Pharma Limited Sponsored ADR (OKYO)

Nutriband Inc. and OKYO Pharma Limited Sponsored ADR are both Biotechnology companies. Nutriband Inc. and OKYO Pharma Limited Sponsored ADR are of similar size ($73.5M and $67.8M). OKYO Pharma Limited Sponsored ADR has the higher net margin (0.00% vs −430.4%) and the higher return on invested capital (0.00% vs −227.9%). Across the 13 metrics below, OKYO Pharma Limited Sponsored ADR leads on 9 and Nutriband Inc. on 4.

Valuation

Metric NTRB OKYO Biotechnology median
P/E n/m n/m 10.60
P/S 41.86 n/m 9.40
P/B 12.71 86.44 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 39.80 n/m 9.02
Earnings yield (10.28%) 0.00% (32.88%)
Free cash flow yield (5.37%) (0.89%) (23.13%)

Profitability

Metric NTRB OKYO Biotechnology median
Gross margin 33.14% 0.00% 68.51%
Operating margin (435.57%) — 0.00%
Net margin (430.43%) 0.00% 0.00%
Free cash flow margin (224.54%) 0.00% 0.00%
Return on equity (100.79%) 0.00% (51.96%)
Return on assets (84.56%) 0.00% (46.06%)
Return on invested capital (227.92%) 0.00% 0.00%

Growth

Metric NTRB OKYO Biotechnology median
Revenue growth (TTM) (37.25%) — 6.76%
EPS growth (last fiscal year) (160.61%) (101.34%) 29.88%
Revenue growth, 5-year CAGR 16.63% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NTRB OKYO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.21 2.43 4.97
Net debt to EBITDA 0.56 2.42 1.01

Dividend

Metric NTRB OKYO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NTRB OKYO Biotechnology median
Market cap 67.77m 73.47m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack